Fears for UK coronavirus patients as the US buys almost the ENTIRE world stock of remdesivir

The US has bought almost the entire global supply of one of only two drugs proven to be effective against coronavirus.         The drug, made by American pharmaceutical firm Gilead, was initially developed as a failed Ebola treatment but studies have now shown it speeds up recovery from coronavirus. However, patients in the UK and Europe … Read more

Fears for UK coronavirus patients as the US buys almost the ENTIRE world stock of remdesivir

The US has bought almost the entire global supply of one of only two drugs proven to be effective against coronavirus.         The drug, made by American pharmaceutical firm Gilead, was initially developed as a failed Ebola treatment but studies have now shown it speeds up recovery from coronavirus. However, patients in the UK and Europe … Read more

US buys nearly all of the global supply of Gilead’s remdesivir

The US government has bought up virtually the entire global supply of remdesivir, the only drug approved in the nation to treat coronavirus, the Department of Health and Human Services (HHS) announced Monday.  That means that any other country will be hard-pressed to get access to the potentially life-saving antiviral medication.  Gilead Sciences, which makes … Read more

The US government’s supply of the remdesivir – will run out at the end of the month

US government’s supply of remdesivir – the only drug shown to work against coronavirus – will run out at the end of the month Redmesivir, made by California-based Gilead Sciences, is the only drug that’s been shown to help shorten the recovery time for coronavirus patients  The US government’s supply is running out and it … Read more

Coronavirus patients taking remdesivir are 65% more likely to see their condition improve by day 11

Coronavirus patients in hospital may be 65 per cent more likely to see their condition improve if they are given the antiviral drug remdesivir, its manufacturer claims. Gilead Sciences, a California-based company that developed the drug in a bid to tackle Ebola, today reported the promising results for Covid-19 patients. After 11 days patients taking … Read more

NHS gets green light to treat coronavirus patients with Ebola drug remdesivir

Coronavirus patients in Britain can now be treated with remdesivir, the Ebola drug which has shown promise in battling the infection.  The Department of Health announced today that adults and teenagers with severe COVID-19 will be allowed to be treated with remdesivir if they fit specific criteria. This makes the drug, which destroys a part of … Read more

NHS gets green light to treat coronavirus patients with Ebola drug remdesivir

Health chiefs grant NHS emergency access to give severely ill Covid-19 patients promising Ebola drug remdesivir Remdesivir has been trialled in NHS hospitals for weeks and shown promise It is a generic virus-destroying drug initially made in a bid to tackle Ebola NHS doctors will now be able to prescribe it to any critically ill … Read more

Gilead looks for global partners to help make its experimental coronavirus drug remdesivir

Gilead Sciences Inc says it is planning to work with international partners to boost production of its experimental coronavirus drug remdesivir. On Friday, the US Food and Drug Administration (FDA) issued emergency use authorization for the medication made by the California-based company.  Remdesivir, which was originally developed as an Ebola drug, is given to hospitalized … Read more

How much will remdesivir cost? Experts say even $10 may be too much for Gilead’s antiviral

Experts say even $10 is too much for the US-made antiviral drug approved to treat the novel coronavirus. Gilead Sciences’ medication, remdesivir, was shown to help reduce patients’ hospital stays over a placebo, in a clinical trial run by the National Institutes of Health. Last week, it became the first drug approved by the US … Read more

Remdesivir trial data ‘offers hope,’ says Gilead CEO

On the heels of an early announcement that coronavirus patients given Gilead’s Ebola drug remdesivir fared better than those who didn’t get the treatment, the company’s CEO, Daniel O’Day, deemed the results a cause for ‘hope at a time when it is badly needed,’ in an open letter obtained by Fox News.   ‘Positive data’ from … Read more